Betaxolol hydrochloride C18H30ClNO3 structure

C18H30ClNO3 structure
Molecular Formula C18H30ClNO3
Average mass 343.889 Da
Density
Boiling Point
Flash Point
Molar Refractivity
Polarizability
Surface Tension
Molar Volume
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      GHS07 Biosynth Q-200714, Q-200715
      H302 Biosynth Q-200714, Q-200715
      P301+P312; P330 Biosynth Q-200714, Q-200715
      Warning Biosynth Q-200714, Q-200715
    • Target Organs:

      Adrenergic Receptor antagonist TargetMol T0226
    • Drug Status:

      USP, INN, BAN, JAN Microsource
      [01505512]
    • Compound Source:

      beta-blocker, antihypertensive, antianginal Microsource
      [01505512]
    • Bio Activity:

      ??-adrenergic receptor TargetMol T0226
      7-TM Receptors Tocris Bioscience 906
      Adrenergic Beta-1 Receptors Tocris Bioscience 906
      Adrenergic Receptor MedChem Express HY-B0381A
      Adrenergic Receptors Tocris Bioscience 906
      Betaxolol Hydrochloride is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma. MedChem Express
      Betaxolol Hydrochloride is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.; Target: Beta1 Adrenergic Receptor; Betaxolol is a cardioselective beta-adrenergic receptor blocking agent. MedChem Express HY-B0381A
      Betaxolol Hydrochloride is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.;Target: Beta1 Adrenergic ReceptorBetaxolol is a cardioselective beta-adrenergic receptor blocking agent. Betaxolol (5 mg/kg via i.p. injection) was administered at 24 and then 44 h following the final chronic cocaine administration. Animals treated with betaxolol during cocaine withdrawal exhibited a significant attenuation of anxiety-like behavior characterized by increased time spent in the open arms and increased entries into the open arms compared to animals treated with only saline during cocaine withdrawal. Betaxolol did not produce anxiolytic-like effects in control animals treated chronically with saline [1]. Betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol. Betaxolol may be relatively safer to use in patients with reactive airway disease than either timolol or levobunolol [2] MedChem Express HY-B0381A
      GPCR/G protein MedChem Express HY-B0381A
      GPCR/G Protein TargetMol T0226
      GPCR/G protein; MedChem Express HY-B0381A
      Selective ?1 antagonist Tocris Bioscience 0906, 906
      Selective ?1-adrenoceptor antagonist. Tocris Bioscience 0906, 906

Predicted data is generated using the ACD/Labs Percepta Platform – PhysChem Module

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site

x

Hi!
I'm Larry

Hi there, would you like to get such a paper? How about receiving a customized one?

Check it out